Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rotavirus vaccine - GlaxoSmithKline

Next Previous
Drug Profile

Rotavirus vaccine - GlaxoSmithKline

Alternative Names: 89-12; GSK 444563; GSK Biologicals' liquid human rotavirus vaccine 444563; GSK rotavirus vaccine 444563; GSK vaccine 444563; HRV Liquid - GlaxoSmithKline; HRV Lyophilized - GlaxoSmithKline; Liq PCV-free HRV; RIX-4414; Rotarix; Rotavirus vaccine - AVANT Immunotherapeutics/GlaxoSmithKline; Rotavirus vaccine 444563 - GlaxoSmithKline; SB-444563

Latest Information Update: 08 Nov 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AVANT Immunotherapeutics; Cincinnati Childrens Hospital Medical Center
  • Developer GlaxoSmithKline; GSK; Japan Vaccine
  • Class Attenuated vaccines; Rotavirus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Rotavirus infections
  • Phase III Gastroenteritis

Most Recent Events

  • 23 Oct 2024 GlaxoSmithKline completes a phase III trial in Gastroenteritis (In infants, In volunteers) in China (PO) (NCT06025695)
  • 22 Oct 2024 GSK completes a phase III trial Rotavirus infections (Prevention, In infants) in China (PO) (NCT06331156)
  • 01 Sep 2023 Phase-III clinical trials in Gastroenteritis (In infants, In volunteers) in China (PO) (NCT06025695)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top